Last Updated: May 14, 2026

DIPHENHYDRAMINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Diphenhydramine patents expire, and what generic alternatives are available?

Diphenhydramine is a drug marketed by Alra, Anabolic, Elkins Sinn, Fosun Pharma, Halsey, Heather, Heritage Pharma, Hikma Intl Pharms, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lederle, LNK, Mk Labs, Mutual Pharm, Newtron Pharms, Nexgen Pharma Inc, Perrigo, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Superpharm, Teva, Valeant Pharm Intl, Vangard, Watson Labs, Whiteworth Town Plsn, Bundy, Cenci, Kv Pharm, Naska, Pharm Assoc, App Pharms, Avet Lifesciences, Bel Mar, Dr Reddys, Gland, Hikma, Hospira, Lyphomed, Micro Labs, Pharmobedient, West-ward Pharms Int, Wyeth Ayerst, Alpharma Us Pharms, Cumberland Swan, Sciegen Pharms, Abraxis Pharm, Fresenius Kabi Usa, and Intl Medication. and is included in seventy-eight NDAs.

The generic ingredient in DIPHENHYDRAMINE is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Diphenhydramine

A generic version of DIPHENHYDRAMINE was approved as diphenhydramine hydrochloride by WEST-WARD PHARMS INT on December 31st, 1969.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for DIPHENHYDRAMINE?
  • What are the global sales for DIPHENHYDRAMINE?
  • What is Average Wholesale Price for DIPHENHYDRAMINE?
Summary for DIPHENHYDRAMINE
US Patents:0
Applicants:52
NDAs:78
Drug Prices: Drug price information for DIPHENHYDRAMINE
DailyMed Link:DIPHENHYDRAMINE at DailyMed

US Patents and Regulatory Information for DIPHENHYDRAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avet Lifesciences DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride INJECTABLE;INJECTION 205337-001 Nov 14, 2025 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Industries DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride CAPSULE;ORAL 089488-001 Jan 2, 1987 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Perrigo DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride CAPSULE;ORAL 083061-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Alpharma Us Pharms DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride SYRUP;ORAL 070497-001 Apr 25, 1989 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Vangard DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride CAPSULE;ORAL 088034-001 Oct 27, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.